Related Experiment Video
Updated: May 9, 2025

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
CK2 control of human papillomavirus life cycles
Apurva T Prabhakar1, Iain M Morgan1,2
16889 Virginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry , Richmond, VA 23298, USA.
Abstract:
Human papillomaviruses are causative agents in around 5 % of all cancers, and in a number of other human diseases. While prophylactic vaccines will alleviate the HPV disease burden on future generations, there are currently no therapeutic anti-viral strategies for combating HPV infections or lesions. HPV induce the proliferation of infected epithelial cells and modulate the host differentiation response, and both of these controls are required for a successful viral life cycle. Enhanced understanding of viral-host interactions during the viral life cycle will identify potential novel anti-viral strategies for therapeutic development. This minireview will summarize the critical role of the host enzyme CK2 in regulating the function of the viral proteins E1, E2 and E7; such control makes CK2 a critical enzyme for regulating HPV life cycles. Therapeutic strategies blocking CK2 function to combat HPV infections and treat HPV diseases will be described.
Insights
Human papillomaviruses (HPVs) cause significant cancers and diseases. This review highlights the host enzyme CK2 as a critical target for developing new anti-viral therapies against HPV infections and lesions.
Area of Science:
- Virology
- Oncology
- Biochemistry
Background:
- Human papillomaviruses (HPVs) are linked to approximately 5% of all human cancers.
- Current prophylactic vaccines address future HPV burdens, but effective therapeutic anti-viral strategies for existing infections and lesions are lacking.
- HPVs manipulate host epithelial cell proliferation and differentiation for viral life cycle completion.
Purpose of the Study:
- To review the critical role of the host enzyme Casein Kinase 2 (CK2) in regulating HPV viral proteins.
- To identify CK2 as a key enzyme controlling HPV life cycles.
- To explore therapeutic strategies targeting CK2 for combating HPV infections and diseases.
Main Methods:
- Literature review focusing on viral-host interactions in HPV life cycles.
- Analysis of the regulatory role of CK2 on HPV proteins E1, E2, and E7.
- Summary of potential therapeutic interventions targeting CK2 function.
Main Results:
- The host enzyme CK2 plays a critical role in regulating the function of HPV proteins E1, E2, and E7.
- CK2 activity is essential for the successful progression of the HPV life cycle.
- Understanding CK2's role provides a basis for novel therapeutic approaches.
Conclusions:
- CK2 is a crucial host factor essential for HPV replication and pathogenesis.
- Targeting CK2 offers a promising therapeutic avenue for treating HPV infections and associated diseases.
- Further research into CK2-targeted therapies could lead to effective treatments for HPV-related conditions.
Related Concept Videos
Inhibition of Cdk Activity
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Retrovirus Life Cycles
Negative Regulator Molecules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

